Screener
MaxCyte MXCT Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: MaxCyte’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:32 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-095971
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other income | 1,358 | 1,870 | 2,793 | 3,904 |
| Loss before income taxes | (8,874) | (12,357) | (13,624) | (22,618) |
| Provision for income taxes | — | — | — | — |
| Net loss | (8,874) | (12,357) | (13,624) | (22,618) |
| Other comprehensive income | — | — | — | — |
| Comprehensive loss | $(8,874) | $(12,357) | $(13,624) | $(22,618) |
| Basic and diluted net loss per share | $(0.08) | $(0.12) | $(0.13) | $(0.21) |
| Weighted-average shares outstanding, basic and diluted | 106,822,633 | 106,403,540 | 106,848,715 | 106,178,262 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is MaxCyte's net income?
- MaxCyte (MXCT) reported net income of -$8.87M in Q2 2026.
- How has MaxCyte's net income changed year-over-year?
- MaxCyte's net income increased by 28.2% year-over-year, from -$12.36M to -$8.87M.
- What is the long-term trend for MaxCyte's net income?
- Over 4 years (2021 to 2025), MaxCyte's net income has grown at a 23.7% compound annual growth rate (CAGR), from -$19.08M to -$44.63M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about MaxCyte's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude